2024/10/18 08:01:50 | |
---|---|
Price | |
7.52 EUR | |
Difference | -2.43% (-0.19) |
ISIN | CA0717341071 |
Symbol | BHC |
Exchange | Munich |
Currency | EUR |
Sector | Other |
Security type | Stock |
Market cap (m) | 2,766 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 7.52 EUR |
High | 7.52 EUR |
Low | 7.52 EUR |
Close (prev. day) | 7.707 EUR |
VWAP | 5.67 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 14 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 08:01:50 | |
---|---|
Price | |
7.52 EUR | |
Difference | -2.43% (-0.19) |
ISIN | CA0717341071 |
Symbol | BHC |
Exchange | Munich |
Currency | EUR |
Sector | Other |
Security type | Stock |
Market cap (m) | 2,766 EUR |
Benchmark | S&P/TSX 60 INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 7.52 EUR |
High | 7.52 EUR |
Low | 7.52 EUR |
Close (prev. day) | 7.707 EUR |
VWAP | 5.67 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -8.26% | +3.55% | -69.13% |
Perf (abs.) | -0.68 | +0.26 | -16.84 |
Beta | 1.37 | 1.69 | 1.77 |
Volatility | 41.77 | 37.57 | 60.48 |
Ø price 5 days | Ø volume 5 days (pcs.) | 7.53 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 6.95 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 6.15 EUR (21) |
Ø price 250 days | Ø volume 250 days (pcs.) | 6.92 EUR (10) |
YTD High | date | 9.80 EUR (2024/04/02) |
YTD Low | date | 4.85 EUR (2024/08/08) |
52 Weeks High | date | 9.80 EUR (2024/04/02) |
52 Weeks Low | date | 4.85 EUR (2024/08/08) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:02 | 7.516 EUR | 0.00 | 1 |
Toronto Stock Exchange | 2024/10/18 | 22:00 | 11.26 CAD | 2.54 | 1,057 |
Stuttgart | 2024/10/18 | 21:31 | 7.492 EUR | 0.00 | 5 |
SIX Swiss Exchange | 2019/06/28 | 17:35 | 24.11 CHF | 0.00 | 1 |
NYSE | 2024/10/18 | 22:00 | 8.16 USD | 12.08 | 10,881 |
Munich | 2024/10/18 | 08:01 | 7.52 EUR | 0.00 | 2 |
Frankfurt | 2024/10/18 | 08:16 | 7.361 EUR | 0.00 | 2 |
Duesseldorf | 2024/10/18 | 08:10 | 7.359 EUR | 0.00 | 3 |
Berlin | 2024/10/18 | 08:01 | 7.361 EUR | 0.00 | 2 |
BAUSCH HEALTH COS. INC. |
- - |
2150 St. Elzéar Boulevard West - H7L 4A8 Laval |
Telefon: +1-514-744-6792 |
Fax: + |
E-mail: - |
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada. |
Thomas Appio | Chairman of Managing Board |
Tage Ramakrishna | Member of Executive Committee |
Cees Heiman | Member of Executive Committee |
Fernando Zarate | Member of Executive Committee |
Graham Jackson | Member of Executive Committee |
Jeff Hartness | Member of Executive Committee |
Kathleen Fitzpatrick | Member of Executive Committee |
Mirza Dautbegovic | Member of Executive Committee |
Seana Carson | Member of Executive Committee |
Tom Vadaketh | Member of Executive Committee |
John Paulson | Chairman of Supervisory Board |
Amy Wechsler | Member of Supervisory Board |
Richard Mulligan | Member of Supervisory Board |
Brett Icahn | Member of Supervisory Board |
Christian Garcia | Member of Supervisory Board |
Frank Lee | Member of Supervisory Board |
Robert Power | Member of Supervisory Board |
Sarah Kavanagh | Member of Supervisory Board |
Steven Miller | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer